Dairy Foods Compared to Dietary Supplements and Bone Health

NCT ID: NCT01394484

Last Updated: 2013-02-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

12 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-12-31

Study Completion Date

2013-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Does the consumption of dairy foods reduce the rate of bone loss in older women more than calcium and vitamin D supplements.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Research indicates that bone health is dependent on multiple nutrients, not just calcium and vitamin D, leading to the conclusion that calcium from sources that include other bone enhancing nutrients may be more effective in maintaining bone integrity than calcium and vitamin D supplements. Several studies have examined the effects of calcium intake from dairy foods on different indicators of bone health. Reducing the rate of bone loss in postmenopausal women can reduce the risk of osteoporosis related fractures. Therefore we propose to study the effectiveness of 4 servings of milk and yogurt per day for 42 days compared to calcium and vitamin D supplements for 42 days to reduce calcium loss from the skeleton in post menopausal women. Postmenopausal women, approximately 50-65 years of age, will be studied. Each volunteer will receive both interventions in a cross-over design, in random order, separated by a 42 day washout period.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Osteoporosis Bone Loss Osteopenia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Arm 1

Four servings of dairy foods per day for 42 days, followed by washout for 42 days, followed by dietary supplements for 42 days

Group Type EXPERIMENTAL

Intervention I

Intervention Type OTHER

Four servings of dairy foods (milk and yogurt) per day for 42 days.

Intervention II

Intervention Type DIETARY_SUPPLEMENT

1200 mg of supplemental calcium and 400 IU of vitamin D3 for 42 days

Arm 2

Dietary Supplements for 42 days, followed by washout for 42 days, followed by 4 servings of dairy foods for 42 days.

Group Type EXPERIMENTAL

Intervention I

Intervention Type OTHER

Four servings of dairy foods (milk and yogurt) per day for 42 days.

Intervention II

Intervention Type DIETARY_SUPPLEMENT

1200 mg of supplemental calcium and 400 IU of vitamin D3 for 42 days

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Intervention I

Four servings of dairy foods (milk and yogurt) per day for 42 days.

Intervention Type OTHER

Intervention II

1200 mg of supplemental calcium and 400 IU of vitamin D3 for 42 days

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Minimum 24 months since last menses
* No hormone therapy in the past 12 months
* Weight stable for the past 3 months
* Bone density T score -1.7 to 0.0
* No more than two dairy servings per day
* No history of inflammatory disorders
* No history of non-traumatic bone fracture
* No supplement use or willing to discontinue
* No lactose intolerance
* Willing to consume milk and yogurt

Exclusion Criteria

* Less than 24 months since last menses
* Use of hormone therapy in past yr
* \> 5 pound weight change in past 3 months
* Osteoporosis
* Regular \>2 servings/d of dairy
* Auto-immune/inflammatory disorders
* History of non-traumatic bone fracture
* Unwilling to discontinue supplements
* Lactose intolerance
* Unwilling to eat yogurt or drink milk
Minimum Eligible Age

50 Years

Maximum Eligible Age

65 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Dairy Management Inc.

INDUSTRY

Sponsor Role collaborator

USDA, Western Human Nutrition Research Center

FED

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Marta Van Loan, PhD

Role: PRINCIPAL_INVESTIGATOR

WHNRC, ARS, University of California Davis

Marjorie Garrod, Ph.D.

Role: STUDY_DIRECTOR

USDA, ARS, WHNRC

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Western Human Nutrition Research Center

Davis, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

WHNRC 201018566-1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Treatment of Vitamin D Insufficiency
NCT00933244 COMPLETED PHASE4
D-Light Intervention
NCT02495584 COMPLETED NA